Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 363, pseudogene (RN7SL363P) is a non-coding RNA classified as a pseudogene of the 7SL RNA gene family. The 7SL RNA is known as the RNA component of the signal recognition particle (SRP), which is essential for targeting secretory proteins to the endoplasmic reticulum in eukaryotes[6]. However, most 7SL-related loci in the genome, including RN7SL363P, are non-functional and do not encode a functional RNA product; instead, they are believed to arise from reverse transcription and integration of RNA back into the genome[1][7]. RN7SL pseudogenes, such as RN7SL363P, display sequence similarity to genuine 7SL RNA genes but typically show truncations or sequence alterations and are not expressed as functional RNAs[7][4]. These pseudogenes are not known to play a therapeutic or biological regulatory role and are not considered targets for drugs or biomarkers. Their presence in the genome primarily serves as evidence of retrotranspositional and evolutionary processes[1][7][4].\n\nKey context:\n- RN7SL363P is an unprocessed pseudogene; not expected to have functional or regulatory roles and is not associated with any known diseases or therapies[4][7].\n- True 7SL RNA is functional in protein targeting, but the pseudogene forms are not functional[1][7][6].\n- There is no evidence for therapeutic targeting, drug interactions, or use as a diagnostic/prognostic biomarker for this specific pseudogene[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 363, pseudogene (RN7SL363P).